Ulrich Rothbauer - Nanotechnology

Author Information

Ulrich Rothbauer is a prolific researcher affiliated with the Pharmaceutical Biotechnology department at Eberhard Karls University, located in Tuebingen, Germany. His work spans multiple facets of biotechnology, with a notable emphasis on nanotechnology and molecular biology.

Research Contributions

In 2022 alone, Ulrich Rothbauer has made significant contributions to various fields, including the study of SARS-CoV-2 vaccination responses, extracellular ion and metabolite dynamics, serological responses to pediatric SARS-CoV-2 infection, and the molecular architecture of signaling complexes in the plasma membrane. His research also delves into the application of nanobody-based tools for monitoring mitochondrial GTPase Miro1, immune responses in dialysis patients post SARS-CoV-2 mRNA vaccination, interactions between anti-PF4 antibodies and anticoagulants, and the dynamics of water and protein in p38α MAP kinase inhibitors. Furthermore, Rothbauer has contributed to advancements in protein N-deglycosylation techniques and Wnt signaling during intestinal regeneration.

Aliases

Ulrich Rothbauer is also known by the aliases U. Rothbauer and Uli Rothbauer.

Publication and Citation Metrics

Metric	Value
Publication Count	142
Citation Count	8137
h-index	40

Publications:

Comparative Magnitude and Persistence of Humoral SARS-CoV-2 Vaccination Responses in the Adult Population in Germany

DOI: 10.3389/fimmu.2022.828053

Year: 2022

Monitoring Extracellular Ion and Metabolite Dynamics with Recombinant Nanobody-Fused Biosensors

DOI: 10.2139/ssrn.4086941

Year: 2022

Robust and durable serological response following pediatric SARS-CoV-2 infection

DOI: 10.1038/s41467-021-27595-9

Year: 2022

Four-color single-molecule imaging with engineered tags resolves the molecular architecture of signaling complexes in the plasma membrane

DOI: 10.1016/j.crmeth.2022.100165

Year: 2022

A Nanobody-Based Toolset to Monitor and Modify the Mitochondrial GTPase Miro1

DOI: 10.3389/fmolb.2022.835302

Year: 2022

Diminishing Immune Responses against Variants of Concern in Dialysis Patients 4 Months after SARS-CoV-2 mRNA Vaccination

DOI: 10.3201/eid2804.211907

Year: 2022

The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia

DOI: 10.1182/blood.2021013839

Year: 2022

Wnt signaling is boosted during intestinal regeneration by a CD44-positive feedback loop

DOI: 10.1038/s41419-022-04607-0

Year: 2022

Decisive role of water and protein dynamics in residence time of p38α MAP kinase inhibitors

DOI: 10.1038/s41467-022-28164-4

Year: 2022

A novel PNGase Rc for improved protein N-deglycosylation in bioanalytics and HDX-MS epitope mapping under challenging conditions

DOI: 10.1101/2022.04.13.488165

Year: 2022

What Advances are Being Made in Ferromagnetic Nanotechnology?

Why are Reduced Defects Important?

What are the Challenges of Using Cloud Computing in Nanotechnology?

What are Selective Reactions?

What Topics are Covered in Nanotechnology Safety Training?

How is Integration Achieved?

How Does Sputtering Work?

What are Porous Templates?

How Does Scale Affect Material Properties?

What Are the Common Techniques for Measurement?

Partnered Content Networks

Relevant Topics